The Vpr gene polymorphism of Human immunodeficiency virus type 1 in China and its clinical significance

Current HIV Research

Volumn 9, Issue 5, 2011, Pages 295-299

  Chen, Xia ^a   Zheng, Yuhuang ^a   Li, Hui ^a   Mamadou, Diallo ^a   Zhang, Chunying ^a   He, Yan ^a   Zhou, Huaying ^a   Chen, Zi ^a   Liu, Meng ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Clinical manifestation; Gene polymorphism; HIV 1 infected patients; Human immunodeficiency virus type 1; Vpr gene; Vpr gene subtype

Indexed keywords

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHINA; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; VIRUS GENE; VPR GENE;

ADOLESCENT; ADULT; CHINA; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, VPR; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RNA, VIRAL; YOUNG ADULT;

EID: 80053983889     PISSN: 1570162X     EISSN: 18734251     Source Type: Journal    
DOI: 10.2174/157016211797635937     Document Type: Article

References (19)

1. Morellet N, Roques BP, Bouaziz S. Structure-function relationship of Vpr. biological implications. Curr HIV Res 2009; 7: 184-210.
2. Zhao RY, Li G, Bukrinsky MI. Vpr-Host Interactions During HIV- 1 Viral Life Cycle. J Neuroimmune Pharmacol 2011; 6(2): 216-29.
3. Ding PP, Zheng YH, Gong GZ, et al. The establishment of a cell strain expressing HIV Vpr and the study on Vpr induced apoptosis. Chinese J Microl Immunol 2008; 28: 545-9.
4. Lum JJ, Cohen OJ, Nie Z, et al. Vpr R77Q is associated with longterm nonprogressive HIV-1 infection and impaired induction of apoptosis. J Clin Invest 2003; 111: 1547-54.
5. Somasundaran M, Sharkey M, Brichacek B, et al. Evidence for a cytopathogenicity determinant in HIV-1 Vpr. Proc Natl Acad Sci USA 2002; 99: 9503-8.
6. Lai M, Chen J. The role of Vpr in HIV-1 disease progression is independent of its G2 arrest induction function. Cell Cycle 2006; 5: 2275-80.
7. Fischer A et al. Is the Vpr R77Q mutation associated with longterm non-progression of HIV-1 infection? AIDS 2004; 18: 1346-7.
8. [Cavert W, Webb CH, Balfour HH Jr. Alterations in the C-terminal region of the HIV-1 accessory gene vpr do not confer clinical advantage to subjects receiving nucleoside antiretroviral therapy. J infect Dis 2004; 189: 2181-4.
9. Jian H, Zhao L J. Pro-apoptotic activity of HIV-1 auxiliary regulatory protein Vpr is subtype-dependent and potently enhanced by nonconservative changes of the leucine residue at position 64. J Biol Chem 2003; 278: 44326-30.
10. Zheng Y, Zhou H, Zhang C, et al. The Apoptosis-Inducing Effects of HIV vpr recombinant eukaryotic expression vectors with different mutation sites on transfected hela cells. Curr HIV Res 2009; 7: 519-25.
11. Zhang Y, Lu L, Ba L, et al. Dominance of HIV-1 subtype CRF01_AE in sexually acquired cases leads to a new epidemic in Yunnan province of China. PLoS Med 2006; 3: e443.
12. Gaynor Chen IS. Analysis of apoptosis induced by HIV-1 Vpr and examination of the possible role of the hHR23A protein. Exp cell Res 2001; 267: 243-57.
13. Rodes B, Toro C, Paxinos E, et al. Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection. AIDS 2004; 18: 1109-16.
14. Ahmad N. Molecular mechanisms of HIV-1 vertical transmission and pathogenesis in infants. Adv Pharmacol 2008; 56: 453-508.
15. Green DR, Kroemer G. The pathophysiology of mitochondrial cell death. Science 2004; 305: 626-9.
16. Cartas M, Singh SP, Serio D, et al. Intravirion display of a peptide corresponding to the dimer structure of protease attenuates HIV-1 replication. DNA Cell Biol 2001; 20: 797-805.
17. Sabbah EN, Druillennec S, Morellet N, et al. Interaction between the HIV-1 protein Vpr and the adenine nucleotide translocator. Chem Biol Drug Des 2006; 67: 145-54.
18. Morellet N, Druillennec S, Lenoir C, et al. Helical structure determined by NMR of the HIV-1 (345-392)Gag sequence, surrounding p2. implications for particle assembly and RNA packaging. Protein Sci 2005; 14: 375-386.
19. Bourbigot S, Beltz H, Denis J, et al. The C-terminal domain of the HIV-1 regulatory protein Vpr adopts an antiparallel dimeric structure in solution via its leucine-zipper-like domain. Biochem J 2005; 387: 333-41.